TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Philip Amrein, MD

Massachusetts General Hospital


Boston, Massachusetts - 02114

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115
  • CLINICAL TRIALS 3
  • CONDITIONS5
  • INTERVENTIONS5
  • SINCE2007
RAD001 in Combination With PKC412 in Patients With Relapsed Refractory or Poor Prognosis AML or MDS

January 2009 - January 2011
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia

June 2008 - December 2010
A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia

November 2007 - November 2010
Leukemia

Leukemia, Myeloid, Acute

Leukemia, Myeloid

Myelodysplastic Syndromes

Preleukemia

Lenalidomide

Rad001

Bortezomib

Pkc412

Cordycepin Plus Pentostatin

Related Investigators

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Patrick Y. Wen, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Kay Kehoe, Coordinator

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Jennifer Brown, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

Rachel A. Freedman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Edwin P. Alyea, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute

F. Stephen Hodi, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana-Farber Cancer Center

Beth A. Overmoyer, MD, FACP

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo